Overview

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Status:
RECRUITING
Trial end date:
2030-06-30
Target enrollment:
Participant gender:
Summary
A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
Phase:
PHASE2
Details
Lead Sponsor:
DualityBio Inc.
Collaborator:
BioNTech SE